TrialCPT: pharmacometrics & systems pharmacology2026

Immunostimulatory and Immunodynamic Modeling Analysis to Determine a Plausible Starting Dose of mRNA-4359 for Use in First-In-Human Trials.

Stephen A Greene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.